4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000899243-22-004186
Options or other derivatives
- Chief Commercial Officer acquired 135,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Vavricka John Chief Commercial Officer | 2022-01-31 | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | D | ||
Loading xslF345X03/doc4.xml…